Themed ‘Exploring New Frontiers in Science’, the conclave focuses on biomedical research, drug discovery, healthcare technologies, biotechnology innovation, and translating scientific research into applications.
The inaugural session was attended by N. Ram, director, The Hindu Group, and L.V. Navaneeth, CEO, The Hindu. It was presided over by G. Viswanathan, founder and chancellor, Vellore Institute of Technology (VIT), with Suchitra Ella, co-founder and managing director, Bharat Biotech and CII President-Designate, as chief guest.
Welcoming the gathering, Suresh Nambath, editor, The Hindu, said the sessions were structured to focus on scientific theory and its practical applications, including the fundamentals of precision medicine, and urged participants to engage with the speakers.
VIT vice-president G.V. Selvam spoke about the institute’s focus on emerging opportunities in innovation and drug discovery. Dr. Viswanathan stressed the importance of gene and precision editing and called for greater focus on education, research, and researchers in India.
Vaccine development in India
Dr. Ella, delivering the inaugural address, spoke about India’s shift from relying on vaccines and molecules developed in the West to building its own research and manufacturing capabilities. She said Indian companies should look beyond the domestic market and develop products for other developing countries, particularly for infectious diseases. She also emphasised championing a ‘One Health’ approach, and strengthening the links between life sciences and food security.Mr. Ram highlighted the contributions of Dr. Viswanathan to education and scientific institution-building, and Dr. Ella to vaccine development and public health. He said the conclave would give students an opportunity to engage with leaders who have contributed to India’s scientific and healthcare ecosystem.
